Contact

Corporate headquarters

XOMA Royalty Corporation
2200 Powell Street, Suite 310
Emeryville, CA 94608
(510) 204-7200

Product and technology licensing and partnerships

We encourage holders of royalty licenses to pre-commercial therapeutic assets that are in active development to contact us regarding our interest in acquiring that license. 

Business Development 
XOMA Royalty Corporation
(510) 204-7200
BizDevInfo@xoma.com

Investors and news media

Shareholders, investors, brokers, analysts and the media may contact our investor relations department:
(510) 204-7276 or InvestorRelations@xoma.com

For inquiries regarding share ownership, transfer, etc., please contact XOMA Royalty’s transfer agent:

Equiniti Trust Company, LLC (“EQ”)
Attention: XOMA Royalty Corporation
55 Challenger Road, Floor 2
Ridgefield Park, NJ 07660

Innovative Platforms for Shareholders | EQ 

Shareholders can email inquiries to helpAST@equiniti.com.

An EQ shareholder services representative can be reached by calling EQ Shareholder Services Call Center at 800.937.5449 or 718-921-8124 Monday through Friday between the hours of 8 a.m. – 8 p.m. Eastern Time. 

© 2026 XOMA Royalty Corporation.  All rights reserved.

Follow us:

Linkedin Twitter

All references to “portfolio” on this website refer strictly to milestone and/or royalty rights associated with a basket of drug products in development.  All references to “assets” on this website refer strictly to milestone and/or royalty rights associated with individual drug product candidates in development.  References to royalties or royalty rates strictly refer to future potential payment streams regardless of whether or not they are technically defined as royalties in the underlying contractual agreement; further, any rates referenced herein are subject to potential future contractual adjustments.